Works matching IS 13520504 AND DT 2018 AND VI 25 AND IP 11
Results: 22
New viral biomarkers for Hepatitis B: Are we able to change practice?
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1226, doi. 10.1111/jvh.12993
- By:
- Publication type:
- Article
Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus: A systematic review and meta‐analysis.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1372, doi. 10.1111/jvh.12964
- By:
- Publication type:
- Article
UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B‐related hepatocellular carcinoma.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1363, doi. 10.1111/jvh.12963
- By:
- Publication type:
- Article
Hepatitis B virus infection and diabetes mellitus: An adverse relationship A letter in response to Incidence and prevalence of hepatitis B in patients with diabetes mellitus in the UK: A population‐based cohort study using the UK Clinical Practice Research Datalink
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1401, doi. 10.1111/jvh.12949
- By:
- Publication type:
- Article
Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)—Estimating HCV incidence in an urban emergency department population.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1397, doi. 10.1111/jvh.12948
- By:
- Publication type:
- Article
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1384, doi. 10.1111/jvh.12947
- By:
- Publication type:
- Article
CD56<sup>bright</sup> natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long‐term entecavir‐treated patients switching to peginterferon alfa‐2a.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1352, doi. 10.1111/jvh.12946
- By:
- Publication type:
- Article
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1298, doi. 10.1111/jvh.12945
- By:
- Publication type:
- Article
Differential expression profile of hepatic circular RNAs in chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1341, doi. 10.1111/jvh.12944
- By:
- Publication type:
- Article
Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1287, doi. 10.1111/jvh.12943
- By:
- Publication type:
- Article
Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1331, doi. 10.1111/jvh.12942
- By:
- Publication type:
- Article
Comparison of effectiveness and discontinuation of interferon‐free therapy for hepatitis C in prison inmates and noninmates.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1280, doi. 10.1111/jvh.12940
- By:
- Publication type:
- Article
Epidemiology and patient characteristics of hepatitis D virus infection in the West of Scotland 2011‐2016.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1395, doi. 10.1111/jvh.12939
- By:
- Publication type:
- Article
Real‐world effectiveness of elbasvir/grazoprevir In HCV‐infected patients in the US veterans affairs healthcare system.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1270, doi. 10.1111/jvh.12937
- By:
- Publication type:
- Article
Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1260, doi. 10.1111/jvh.12936
- By:
- Publication type:
- Article
Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1321, doi. 10.1111/jvh.12934
- By:
- Publication type:
- Article
Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1312, doi. 10.1111/jvh.12933
- By:
- Publication type:
- Article
Evolution and persistence of resistance‐associated substitutions of hepatitis C virus after direct‐acting antiviral treatment failures.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1251, doi. 10.1111/jvh.12932
- By:
- Publication type:
- Article
Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource‐limited settings by Loop‐Mediated Isothermal Amplification assay.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1306, doi. 10.1111/jvh.12931
- By:
- Publication type:
- Article
Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP).
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1244, doi. 10.1111/jvh.12930
- By:
- Publication type:
- Article
Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance‐based propensity score matching approach.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1236, doi. 10.1111/jvh.12929
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1223, doi. 10.1111/jvh.12780
- Publication type:
- Article